Abboud H, Yu XX, Knusel K, et al. Movement disorders in early MS and related diseases: A prospective observational study. Neurol Clin Pract., Feb 2019; 9(1): 24–31. Epub ahead of print. DOI: https://doi.org/10.1212/CPJ.0000000000000560 

Potulska-Chromik A, Rudzinska M, Nojszewska M, et al. Clinical and neuroimaging correlation of movement disorders in multiple sclerosis: case series and review of the literature. Folia Neuropathol., 2014; 52: 92–100. DOI: https://doi.org/10.5114/fn.2014.41747 

Mehanna R, Jankovic J. Movement disorders in multiple sclerosis and other demyelinating diseases. J Neurol Sci., 2013; 328: 1–8. DOI: https://doi.org/10.1016/j.jns.2013.02.007 

Nociti V, Bentivoglio AR, Frisullo G, et al. Movement disorders in multiple sclerosis: Causal or coincidental association? Mult Scler., Nov 2008; 14(9): 1284-7. DOI: https://doi.org/10.1177/1352458508094883 

Alusi SH, Worthington J, Glickman S, et al. A study of tremor in multiple sclerosis. Brain., Apr 2001; 124(Pt 4): 720–30. DOI: https://doi.org/10.1093/brain/124.4.720 

Suarez-Cedeno G, Mehanna R. Movement Disorders in Multiple Sclerosis and Other Demyelinating Diseases: A Retrospective Review From a Tertiary Academic Center. Neurologist., Sept 2021; 26(5): 161–166. Epub ahead of print. DOI: https://doi.org/10.1097/NRL.0000000000000333 

Zecca C, Manconi M, Fulda S, et al. Restless legs syndrome in multiple sclerosis. CNS Neurol Disord Drug Targets., Dec 2012; 11(8): 1061–9. DOI: https://doi.org/10.2174/1871527311211080017 

Giannaki CD, Aristotelous P, Stefanakis M, et al. Restless legs syndrome in Multiple Sclerosis patients: a contributing factor for fatigue, impaired functional capacity, and diminished health-related quality of life. Neurol Res., Jul 2018; 40(7): 586–592. DOI: https://doi.org/10.1080/01616412.2018.1454719 

Cederberg KLJ, Jeng B, Sasaki JE, et al. Restless legs syndrome and health-related quality of life in adults with multiple sclerosis. J Sleep Res., Jun 2020; 29(3): e12880. Epub ahead of print. DOI: https://doi.org/10.1111/jsr.12880 

Liu G, Feng X, Lan C, et al. Restless leg syndrome and multiple sclerosis: a case-control study in China. Sleep Breath., Dec 2015; 19(4): 1355–60. DOI: https://doi.org/10.1007/s11325-015-1201-3 

Group IREMSS, Manconi M, Ferini-Strambi L, et al. Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep., Jul 2008; 31(7): 944–52. 

Manconi M, Fabbrini M, Bonanni E, et al. High prevalence of restless legs syndrome in multiple sclerosis. Eur J Neurol; May 2007; 14(5): 534–9. DOI: https://doi.org/10.1111/j.1468-1331.2007.01740.x 

Miri S, Rohani M, Sahraian MA, et al. Restless legs syndrome in Iranian patients with multiple sclerosis. Neurol Sci., Jul 2013; 34(7): 1105–8. Epub ahead of print. DOI: https://doi.org/10.1007/s10072-012-1186-7 

Aydar G, Kurt S, Karaer Unaldi H, et al. Restless legs syndrome in multiple sclerosis. Eur Neurol., 2011; 65: 302–6. DOI: https://doi.org/10.1159/000327315 

Sieminski M, Losy J, Partinen M. Restless legs syndrome in multiple sclerosis. Sleep Med Rev., 2015; 22: 15–22. DOI: https://doi.org/10.1016/j.smrv.2014.10.002 

Douay X, Waucquier N, Hautecoeur P, et al. G-SEP (Groupe Septentrional d’Etudes et de Recherche sur la Sclérose en Plaques). Prévalence élevée du syndrome des jambes sans repos dans la sclérose en plaques [High prevalence of restless legs syndrome in multiple sclerosis. Rev Neurol (Paris)., Feb 2009; 165(2): 194–6. DOI: https://doi.org/10.1016/j.neurol.2008.06.001 

Ozdogar AT, Kalron A. Restless legs syndrome in people with multiple sclerosis: An updated systematic review and meta-analyses. Mult Scler Relat Disord., Nov 2021; 56: 103275. DOI: https://doi.org/10.1016/j.msard.2021.103275 

Monschein T, Schestak C, Schillerwein-Kral C, et al. Restless Legs Syndrome in Multiple Sclerosis: Risk factors and effect on sleep quality – a case-control study. Mult Scler Relat Disord., Jun 2021; 51: 102916. DOI: https://doi.org/10.1016/j.msard.2021.102916 

Trenkwalder C, Allen R, Högl B, et al. Restless legs syndrome associated with major diseases: A systematic review and new concept. Neurology; 5 2016; 86(14): 1336–1343. DOI: https://doi.org/10.1212/WNL.0000000000002542 

Sünter G, Kilinç Ö, Berk A, et al. Restless Legs Syndrome/Willis-Ekbom Disease in Multiple Sclerosis Patients with Spinal Cord Lesions., March 2019; 57(4): 299–302. DOI: https://doi.org/10.29399/npa.23351 

Baba C, Ozdogar AT, Ozcelik S, et al. Relationship between presence of spinal cord lesion and restless legs syndrome in multiple sclerosis. Somatosens Mot Res., 2022; 18: 1–5. DOI: https://doi.org/10.1080/08990220.2022.2027360 

Li Y, Munger KL, Batool-Anwar S, et al. Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women. Neurology., May 2012; 78(19): 1500–6. DOI: https://doi.org/10.1212/WNL.0b013e3182553c5b 

Chenini S, Delaby C, Rassu AL, et al. Hepcidin and ferritin levels in restless legs syndrome: a case-control study. Sci Rep., July 2020; 10(1): 11914. DOI: https://doi.org/10.1038/s41598-020-68851-0 

Comella CL. Treatment of restless legs syndrome. Neurotherapeutics., Jan 2014; 11(1): 177–87. DOI: https://doi.org/10.1007/s13311-013-0247-9 

Ashizawa T, Continuum XGA. Ataxia. Continuum (Movement Disorders)., Aug 2016; 1208–26. DOI: https://doi.org/10.1212/CON.0000000000000362 

Garcia-Borreguero D, Benitez A, Kohnen R, et al. Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment. Postgrad Med., 2015; 127: 716–25. DOI: https://doi.org/10.1080/00325481.2015.1058140 

Earley CJ, Uhl GR, Clemens S, et al. Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation. Sleep Med., 2017; 31: 71–77. DOI: https://doi.org/10.1016/j.sleep.2016.06.003 

Makhoul K, Ahdab R, Riachi N, et al. Tremor in Multiple Sclerosis—An Overview and Future Perspectives. Brain Sci., October 2020; 10(10): 722. Epub ahead of print. DOI: https://doi.org/10.3390/brainsci10100722 

Koch M, Mostert J, Heersema D, et al. Tremor in multiple sclerosis. J Neurol., Feb 2007; 254(2): 133–45. DOI: https://doi.org/10.1007/s00415-006-0296-7 

Labiano-Fontcuberta A, Benito-León J. Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment. Tremor Other Hyperkinet Mov (N Y). 2012; 2: tre-02-109-765-2. DOI: https://doi.org/10.7916/D8Z60MR3 

Christogianni A, Bibb R, Davis SL, et al. Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms. Temperature (Austin. 5 September 2018; 5(3): 208–223. DOI: https://doi.org/10.1080/23328940.2018.1475831 

Walt AV, KB, SS, et al. The occurrence of dystonia in upper-limb multiple sclerosis tremor. Mult Scler., Dec 2015; 21(14): 1847–55. DOI: https://doi.org/10.1177/1352458515577690 

Boonstra FM, Noffs G, Perera T, et al. Functional neuroplasticity in response to cerebello-thalamic injury underpins the clinical presentation of tremor in multiple sclerosis. Mult Scler. May 2020; 26(6): 696–705. DOI: https://doi.org/10.1177/1352458519837706 

Boonstra F, Florescu G, Evans A, et al. Tremor in multiple sclerosis is associated with cerebello-thalamic pathology. J Neural Transm (Vienna)., Dec 2017; 124(12): 1509–1514. DOI: https://doi.org/10.1007/s00702-017-1798-4 

Feys P, Maes F, Nuttin B, et al. Relationship between multiple sclerosis intention tremor severity and lesion load in the brainstem. Neuroreport., August 2005; 16(12): 1379–82. DOI: https://doi.org/10.1097/01.wnr.0000176521.26971.58 

Yerdelen D, Karatas M, Aydin M. Generalized Chorea Associated With Nonketotic Hyperglycemia: Cerebral MRI and SPECT Findings. Neurosurgery Quarterly., 2008; 18: 72–3. DOI: https://doi.org/10.1097/WNQ.0b013e3181644eec 

Alqwaifly M. Treatment responsive Holmes tremor: case report and literature review. Int J Health Sci (Qassim)., Oct; 10(4): 558–562. DOI: https://doi.org/10.12816/0048905 

Yerdelen D, Karatas M, Goksel B, et al. A patient with multiple sclerosis presenting with Holmes’ tremor. Eur J Neurol., Jan 2008; 15(1): e2–3. DOI: https://doi.org/10.1111/j.1468-1331.2007.01984.x 

Francis DA, Grundy D, Heron J. The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry. J Neurol Neurosurg Psychiatry., Jan 1986; 49(1): 87–9. DOI: https://doi.org/10.1136/jnnp.49.1.87 

Morrow J, McDowell H, Ritchie C, et al. Isoniazid and action tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry., Mar 1985; 48(3): 282–3. DOI: https://doi.org/10.1136/jnnp.48.3.282 

Sabra AF, Hallett M, Sudarsky L, et al. Treatment of action tremor in multiple sclerosis with isoniazid. Neurology., Aug 1982; 32(8): 912–3. DOI: https://doi.org/10.1212/WNL.32.8.912 

Duquette P, Pleines J, Souich P. Isoniazid for tremor in multiple sclerosis: a controlled trial. Neurology., Dec 1985; 35(12): 1772–5. DOI: https://doi.org/10.1212/WNL.35.12.1772 

Hart FM, Bainbridge J. Current and emerging treatment of multiple sclerosis. Am J Manag Care., Jun 2016; 22(6 Suppl): s159–70. PMID: 27356025. 

Prieto González JM. Tratamiento sintomático y del brote de esclerosis múltiple [Treatment of multiple sclerosis symptoms and exacerbations]. Med Clin (Barc)., 2014; 143 Suppl 3: 39–43. DOI: https://doi.org/10.1016/S0025-7753(15)30009-9 

Sailer M, Lindquist S, Sickert A, et al. Multiple Sklerose: Neurorehabilitation und symptomatische Therapie [Multiple Sclerosis: Neurorehabilitation and Symptomatic Treatment]. Rehabilitation (Stuttg)., 2019; 58(5): 339–50. DOI: https://doi.org/10.1055/a-0755-1398 

Fox P, Bain PG, Glickman S, et al. The effect of cannabis on tremor in patients with multiple sclerosis. Neurology., 13 2004; 62(7): 1105–9. DOI: https://doi.org/10.1212/01.WNL.0000118203.67138.3E 

Zajicek JP, Apostu V. Role of cannabinoids in multiple sclerosis. CNS Drugs., Mar 2011; 25(3): 187–201. DOI: https://doi.org/10.2165/11539000-000000000-00000 

Nielsen S, Germanos R, Weier M, et al. The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews. Curr Neurol Neurosci Rep., Feb 2018; 18(2): 8. DOI: https://doi.org/10.1007/s11910-018-0814-x 

Schniepp R, Jakl V, Wuehr M, et al. Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report. Mult Scler., Apr 2013; 19(4): 506–8. DOI: https://doi.org/10.1177/1352458512461394 

Schroeder A, Linker RA, Lukas C, et al. Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case report. Clin Neuropharmacol., 2010; 33(6): 317–8. DOI: https://doi.org/10.1097/WNF.0b013e3181f84a39 

Mittal SO, Lenka A, Jankovic J. Botulinum toxin for the treatment of tremor. Parkinsonism Relat Disord., 2019; 63: 31–41. DOI: https://doi.org/10.1016/j.parkreldis.2019.01.023 

Habek M, Karni A, Balash Y, et al. The place of the botulinum toxin in the management of multiple sclerosis. Clin Neurol Neurosurg., Sep 2010; 112(7): 592–6. DOI: https://doi.org/10.1016/j.clineuro.2010.04.010 

Van Der Walt A, Sung S, Spelman T, et al. A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor. Neurology., July 2012; 79(1): 92–9. DOI: https://doi.org/10.1212/WNL.0b013e31825dcdd9 

Feys P, D’hooghe MB, Nagels G, et al. The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis. Mult Scler., Mar 2009; 15(3): 371–8. DOI: https://doi.org/10.1177/1352458508099142 

Chitsaz A, Mehrbod N, Etemadifar M, et al. Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis. J Res Med Sci., Mar 2013; 18(Suppl 1): S78–80. 

Striano P, Coppola A, Vacca G, et al. Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study. J Neurol., Jun 2006; 253(6): 762–6. DOI: https://doi.org/10.1007/s00415-006-0112-4 

Solaro C, Sire A, Messmer Uccelli M, et al. Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover study. Eur J Neurol., Nov 2020; 27(11): 2209–2216. DOI: https://doi.org/10.1111/ene.14403 

Gbadamosi J, Buhmann C, Moench A, et al. Failure of ondansetron in treating cerebellar tremor in MS patients–an open-label pilot study. Acta Neurol Scand., 2001 Nov; 104(5): 308–11. DOI: https://doi.org/10.1034/j.1600-0404.2001.00075.x 

Naderi F, Javadi SA, Motamedi M, et al. The efficacy of primidone in reducing severe cerebellar tremors in patients with multiple sclerosis. Clin Neuropharmacol. Sep–Oct 2012; 35(5): 224–6. DOI: https://doi.org/10.1097/WNF.0b013e31826249bb 

Sechi GP, Zuddas M, Piredda M, et al. Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up. Neurology., Aug 1989; 39(8): 1113–5. DOI: https://doi.org/10.1212/WNL.39.8.1113 

Koller WC. Pharmacologic trials in the treatment of cerebellar tremor. Arch Neurol., Mar 1984; 41(3): 280–1. DOI: https://doi.org/10.1001/archneur.1984.04050150058017 

Deuschl G. Movement disorders in multiple sclerosis and their treatment. Neurodegener Dis Manag., Dec 2016; 6(6s): 31–35. DOI: https://doi.org/10.2217/nmt-2016-0053 

Bittar RG, Hyam J, Nandi D, et al. Thalamotomy versus thalamic stimulation for multiple sclerosis tremor. J Clin Neurosci., Aug 2005; 12(6): 638–42. DOI: https://doi.org/10.1016/j.jocn.2004.09.008 

Matsumoto J, Morrow D, Kaufman K, et al. Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures. Neurology., November 2001; 57(10): 1876–82. DOI: https://doi.org/10.1212/WNL.57.10.1876 

Alusi SH, Aziz TZ, Glickman S, et al. Stereotactic lesional surgery for the treatment of tremor in multiple sclerosis: a prospective case-controlled study. Brain., Aug 2001; 124(Pt 8): 1576–89. DOI: https://doi.org/10.1093/brain/124.8.1576 

Niranjan A, Kondziolka D, Baser S, et al. Functional outcomes after gamma knife thalamotomy for essential tremor and MS-related tremor. Neurology., August 2000; 55(3): 443–6. DOI: https://doi.org/10.1212/WNL.55.3.443 

Schuurman PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med., February 2000; 342(7): 461–8. DOI: https://doi.org/10.1056/NEJM200002173420703 

Nandi D, Aziz TZ. Deep brain stimulation in the management of neuropathic pain and multiple sclerosis tremor. J Clin Neurophysiol., Jan–Feb 2004; 21(1): 31–9. DOI: https://doi.org/10.1097/00004691-200401000-00005 

Schulder M, Sernas TJ, Karimi R. Thalamic stimulation in patients with multiple sclerosis: long-term follow-up. Stereotact Funct Neurosurg., 2003; 80: 48–55. DOI: https://doi.org/10.1159/000075160 

Wishart HA, Roberts DW, Roth RM, et al. Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports. J Neurol Neurosurg Psychiatry., Oct 2003; 74(10): 1392–7. DOI: https://doi.org/10.1136/jnnp.74.10.1392 

Berk C, Carr J, Sinden M, et al. Thalamic deep brain stimulation for the treatment of tremor due to multiple sclerosis: a prospective study of tremor and quality of life. J Neurosurg., Oct 2002; 97(4): 815–20. DOI: https://doi.org/10.3171/jns.2002.97.4.0815 

Nandi D, Chir M, Liu X, et al. Electrophysiological confirmation of the zona incerta as a target for surgical treatment of disabling involuntary arm movements in multiple sclerosis: use of local field potentials. J Clin Neurosci., Jan 2002; 9(1): 64–8. DOI: https://doi.org/10.1054/jocn.2001.1012 

Hooper J, Taylor R, Pentland B, et al. A prospective study of thalamic deep brain stimulation for the treatment of movement disorders in multiple sclerosis. Br J Neurosurg., Apr 2002; 16(2): 102–9. DOI: https://doi.org/10.1080/02688690220131769 

Loher TJ, Gutbrod K, Fravi NL, et al. Thalamic stimulation for tremor. Subtle changes in episodic memory are related to stimulation per se and not to a microthalamotomy effect. J Neurol., Jun 2003; 250(6): 707–13. DOI: https://doi.org/10.1007/s00415-003-1067-3 

Krauss JK, RK S, Jr., Ondo WG, et al. Concepts and methods in chronic thalamic stimulation for treatment of tremor: technique and application. Neurosurgery., 2001 Mar; 48(3): 535–41, 541–3. DOI: https://doi.org/10.1097/00006123-200103000-00015 

Matsumoto J, Morrow D, Kaufman K, et al. Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures. Neurology., November 2001; 57(10): 1876–82. DOI: https://doi.org/10.1212/WNL.57.10.1876 

Schuurman PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med., February 2000; 342(7): 461–8. DOI: https://doi.org/10.1056/NEJM200002173420703 

Oliveria SF, Rodriguez RL, Bowers D, et al. Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial. Lancet Neurol., Sep 2017; 16(9): 691–700. DOI: https://doi.org/10.1016/S1474-4422(17)30166-7 

Yap L, Kouyialis A, Varma TR. Stereotactic neurosurgery for disabling tremor in multiple sclerosis: thalamotomy or deep brain stimulation? Br J Neurosurg., Aug 2007; 21(4): 349–54. DOI: https://doi.org/10.1080/02688690701544002 

Hyam JA, Aziz TZ, Bain PG. Post-deep brain stimulation–gradual non-stimulation dependent decrease in strength with attenuation of multiple sclerosis tremor. J Neurol., Jul 2007; 254(7): 854–60. DOI: https://doi.org/10.1007/s00415-006-0433-3 

Máñez-Miró JU, Martínez-Fernández R, Del Alamo M, et al. Focused ultrasound thalamotomy for multiple sclerosis-associated tremor. Mult Scler., Jun 2020; 26(7): 855–858. DOI: https://doi.org/10.1177/1352458519861597 

Mathieu D, Kondziolka D, Niranjan A, et al. Gamma knife thalamotomy for multiple sclerosis tremor. Surg Neurol., Oct 2007; 68(4): 394–9. DOI: https://doi.org/10.1016/j.surneu.2006.11.049 

Hosseini H, Mandat T, Waubant E, et al. Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis. Neurosurgery., Jan 2012; 70(1): 66–9. DOI: https://doi.org/10.1227/NEU.0b013e31822da55c 

Hassan A, Ahlskog JE, Rodriguez M, et al. Surgical therapy for multiple sclerosis tremor: a 12-year follow-up study. Eur J Neurol., May 2012; 19(5): 764–8. DOI: https://doi.org/10.1111/j.1468-1331.2011.03626.x 

Moore GR, Vitali AM, Leung E, et al. Thalamic stimulation in multiple sclerosis: evidence for a ‘demyelinative thalamotomy’. Mult Scler. 2009; 15(11): 1311–21. DOI: https://doi.org/10.1177/1352458509345914 

Benito-León J, Louis ED. Movement disorders: New hope for medically-refractory essential tremor? Nat Rev Neurol., October 2016; 12(11): 618–619. DOI: https://doi.org/10.1038/nrneurol.2016.162 

Lim DA, Khandhar SM, Heath S, et al. Multiple target deep brain stimulation for multiple sclerosis related and poststroke Holmes’ tremor. Stereotact Funct Neurosurg., 2007; 85: 144–9. DOI: https://doi.org/10.1159/000099072 

Mills RJ, Yap L, Young CA. Treatment for ataxia in multiple sclerosis. Cochrane Database Syst Rev., 2007; (1): CD005029. DOI: https://doi.org/10.1002/14651858.CD005029.pub2 

Pandolfo M, Manto M. Cerebellar and afferent ataxias. Continuum (Minneap Minn). Oct 2013; 19(5 Movement Disorders): 1312–43. DOI: https://doi.org/10.1212/01.CON.0000436158.39285.22 

Mitoma H, Buffo A, Gelfo F, et al. Consensus Paper. Cerebellar Reserve: From Cerebellar Physiology to Cerebellar Disorders. Cerebellum., Feb 2020; 19(1): 131–153. DOI: https://doi.org/10.1007/s12311-019-01091-9 

Vidailhet M, Jedynak CP, Pollak P, et al. Pathology of symptomatic tremors. Mov Disord., 1998; 13 Suppl 3: 49–54. DOI: https://doi.org/10.1002/mds.870131309 

Zhang Q, Zhou X, Li Y, et al. Clinical Recognition of Sensory Ataxia and Cerebellar Ataxia. Front Hum Neurosci., 2021 Apr 1; 15: 639871. DOI: https://doi.org/10.3389/fnhum.2021.639871 

Karmon Y, Morrow SA, Weinstock A, et al. Limb ataxia originating from peri-central sulcus demyelinating lesion in multiple sclerosis. J Neurol Sci., September 2012; 320(1–2): 136–40. Epub ahead of print. DOI: https://doi.org/10.1016/j.jns.2012.05.039 

Gorman MJ. Multiple sclerosis presenting as ataxic hemiparesis. J Neurol Sci., May 2002; 197(1–2): 85–7. Epub ahead of print. DOI: https://doi.org/10.1016/S0022-510X(02)00045-X 

Marcel C, Anheim M, Flamand-Rouvière C, et al. Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases. J Neurol., Aug 2010; 257(8): 1369–72. DOI: https://doi.org/10.1007/s00415-010-5534-3 

Batum M, Kısabay Ak A, Çetin G, et al. Coincidental occurance of episodic ataxia and multiple sclerosis: a case report and review of the literature. Int J Neurosci., 2020; 20: 1–6. DOI: https://doi.org/10.1080/00207454.2020.1835896 

Freiha J, Riachi N, Chalah MA, et al. Paroxysmal Symptoms in Multiple Sclerosis-A Review of the Literature. J Clin Med., September 2020; 9(10): 3100. DOI: https://doi.org/10.3390/jcm9103100 

Twomey JA, Espir ML. Paroxysmal symptoms as the first manifestations of multiple sclerosis. J Neurol Neurosurg Psychiatry., Apr 1980; 43(4): 296–304. DOI: https://doi.org/10.1136/jnnp.43.4.296 

Iorio R, Capone F, Plantone D, et al. Paroxysmal ataxia and dysarthria in multiple sclerosis. J Clin Neurosci., Jan 2014; 21(1): 174–5. DOI: https://doi.org/10.1016/j.jocn.2013.01.031 

Li Y, Zeng C, Luo T. Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings. J Neurol., Feb 2011; 258(2): 273–6. DOI: https://doi.org/10.1007/s00415-010-5748-4 

Papastergios C, Shaker A, Schiopu-Mariean BL, et al. Paroxysmal dysartri och ataxi – en ovanlig manifestation vid MS [Paroxysmal dysarthria and ataxia – unusual MS manifestation]. Lakartidningen., 2021; 118: 21022. 

Lilleker JB, Gall C, Dayanandan R, et al. Paroxysmal dysarthria ataxia syndrome responds to lacosamide. Mult Scler., Feb 2015; 21(2): 256. DOI: https://doi.org/10.1177/1352458514546792 

Rossi S, Studer V, Motta C, et al. Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment. J Neurol Sci., March 2015; 350(1–2): 101–2. DOI: https://doi.org/10.1016/j.jns.2015.01.023 

Gorard DA, Gibberd FB. Paroxysmal dysarthria and ataxia: associated MRI abnormality. J Neurol Neurosurg Psychiatry., Dec 1989; 52(12): 1444–5. DOI: https://doi.org/10.1136/jnnp.52.12.1444 

Goodwin SJ, Carpenter AF. Successful treatment of paroxysmal ataxia and dysarthria in multiple sclerosis with levetiracetam. Mult Scler Relat Disord., Nov 2016; 10: 79–81. Epub ahead of print. DOI: https://doi.org/10.1016/j.msard.2016.09.003 

Klaas JP, Burkholder DB, Singer W, et al. Harry Lee Parker and paroxysmal dysarthria and ataxia. Neurology., 2013; 80(3): 311–4. DOI: https://doi.org/10.1212/WNL.0b013e31827dec0f 

Zavalishin IA, Nevskaia OM, Niiazbekova AS. Paroksizmal’nye pristupy dizartrii i ataksii pri rasseiannom skleroze [Paroxysmal attacks of dysarthria and ataxia in multiple sclerosis]. Zh Nevropatol Psikhiatr Im S S Korsakova., 1978; 78(11): 1645–9. 

Shah S, Klassen BT, Flanagan EP. Teaching Video NeuroImages: Paroxysmal Dysarthria-Ataxia in Multiple Sclerosis. Neurology., 27 2021; 96(17): e2245–e2246. DOI: https://doi.org/10.1212/WNL.0000000000011498 

Ostermann PO, Westerberg CE. Paroxysmal attacks in multiple sclerosis. Brain., Jun 1975; 98(2): 189–202. DOI: https://doi.org/10.1093/brain/98.2.189 

Skillrud DM, Goldstein NP. Paroxysmal limb hemiataxia with crossed facial paresthesias in multiple sclerosis. JAMA., 250(20): 2843–4. DOI: https://doi.org/10.1001/jama.250.20.2843 

Armutlu K, Karabudak R, Nurlu G. Physiotherapy approaches in the treatment of ataxic multiple sclerosis: a pilot study. Neurorehabil Neural Repair., 2001; 15: 203–11. DOI: https://doi.org/10.1177/154596830101500308 

Wiles CM, Newcombe RG, Fuller KJ, et al. Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry., Feb 2001; 70(2): 174–9. DOI: https://doi.org/10.1136/jnnp.70.2.174 

Lord SE, Wade DT, Halligan PW. A comparison of two physiotherapy treatment approaches to improve walking in multiple sclerosis: a pilot randomized controlled study. Clin Rehabil., Dec 1998; 12(6): 477–86. DOI: https://doi.org/10.1191/026921598675863454 

Gibson-Horn C. Balance-based torso-weighting in a patient with ataxia and multiple sclerosis: a case report. J Neurol Phys Ther., Sep 2008; 32(3): 139–46. DOI: https://doi.org/10.1097/NPT.0b013e318185558f 

Crittendon A, O’Neill D, Widener GL, et al. Standing data disproves biomechanical mechanism for balance-based torso-weighting. Arch Phys Med Rehabil., Jan 2014; 95(1): 43–9. DOI: https://doi.org/10.1016/j.apmr.2013.08.235 

Gorgas AM, Widener GL, Gibson-Horn C, et al. Gait changes with balance-based torso-weighting in people with multiple sclerosis. Physiother Res Int., Mar 2015; 20(1): 45–53. DOI: https://doi.org/10.1002/pri.1595 

Widener GL, Conley N, Whiteford S, et al. Changes in standing stability with balance-based torso-weighting with cerebellar ataxia: A pilot study. Physiother Res Int., Jan 2020; 25(1): e1814. DOI: https://doi.org/10.1002/pri.1814 

Ali AS, Darwish MH, Shalaby NM, et al. Efficacy of core stability versus task oriented trainings on balance in ataxic persons with multiple sclerosis. A single blinded randomized controlled trial. Mult Scler Relat Disord., 2021; 50: 102866. DOI: https://doi.org/10.1016/j.msard.2021.102866 

Salcı Y, Fil A, Armutlu K, et al. Effects of different exercise modalities on ataxia in multiple sclerosis patients: a randomized controlled study. Disabil Rehabil., Dec 2017; 39(26): 2626–2632. DOI: https://doi.org/10.1080/09638288.2016.1236411 

Scheidler AM, Kinnett-Hopkins D, Learmonth YC, et al. Targeted ballet program mitigates ataxia and improves balance in females with mild-to-moderate multiple sclerosis. PLoS One., October 2018; 13(10): e0205382. DOI: https://doi.org/10.1371/journal.pone.0205382 

Oakes PK, Srivatsal SR, Davis MY, et al. Movement disorders in multiple sclerosis. Phys Med Rehabil Clin N Am., 2013; 24(4): 639–51. DOI: https://doi.org/10.1016/j.pmr.2013.06.003 

Perlman SL. Cerebellar Ataxia. Curr Treat Options Neurol., May 2000; 2(3): 215–224. DOI: https://doi.org/10.1007/s11940-000-0004-3 

Bourdette D, Gilden D. Fingolimod and multiple sclerosis: four cautionary tales. Neurology., November 2012; 79(19): 1942–3. DOI: https://doi.org/10.1212/WNL.0b013e3182735edf 

Berger JR, Sheremata WA, Melamed E. Paroxysmal dystonia as the initial manifestation of multiple sclerosis. Arch Neurol., Jul 1984; 41(7): 747–50. DOI: https://doi.org/10.1001/archneur.1984.04050180069020 

Machado C, Amorim JM, Rodrigues M, et al. Paroxysmal dystonia as a manifestation of multiple sclerosis. Neurologist., May 2015; 19(5): 132–4. DOI: https://doi.org/10.1097/NRL.0000000000000025 

Yilmaz S, Serdaroglu G, Gokben S, et al. Paroxysmal dystonia as a rare initial manifestation of multiple sclerosis. J Child Neurol., Dec 2011; 26(12): 1564–6. DOI: https://doi.org/10.1177/0883073811410882 

Rajabally YA, Farrell D, Messios N. Oro-mandibular dystonia in a case of multiple sclerosis with capsular plaque. Eur Neurol., 2003; 49: 190–1. DOI: https://doi.org/10.1159/000069084 

Thompson PD, Obeso JA, Delgado G, et al. Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. J Neurol Neurosurg Psychiatry., Jun 1986; 49(6): 651–6. DOI: https://doi.org/10.1136/jnnp.49.6.651 

Coleman RJ, Quinn NP, Marsden CD. Multiple sclerosis presenting as adult onset dystonia. Mov Disord., 1988; 3: 329–32. DOI: https://doi.org/10.1002/mds.870030408 

Fontoura P, Vale J, Guimarães J. Symptomatic paroxysmal hemidystonia due to a demyelinating subthalamic lesion. Eur J Neurol., Sep 2000; 7(5): 559–62. DOI: https://doi.org/10.1046/j.1468-1331.2000.t01-1-00110.x 

Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol., Oct 1995; 38(4): 571–9. DOI: https://doi.org/10.1002/ana.410380405 

Waubant E, Alizé P, Tourbah A, et al. Paroxysmal dystonia (tonic spasm) in multiple sclerosis. Neurology., December 2001; 57(12): 2320–1. DOI: https://doi.org/10.1212/WNL.57.12.2320 

Restivo DA, Solaro C, Maimone D, et al. Pharyngeal painful tonic spasms: paroxysmal painful swallowing. Ann Intern Med., Nov 2011; 155(9): 649–50. DOI: https://doi.org/10.7326/0003-4819-155-9-201111010-00024 

Andrade C, Massano J, Guimarães J, et al. Stretching the limbs? Tonic spasms in multiple sclerosis. BMJ Case Rep., November 2012; 2012: bcr2012007513. DOI: https://doi.org/10.1136/bcr-2012-007513